To confirm the pivotal role of RPRD1A in repressing the expression of SOX9 and CD44 in GC, we initially assessed the expression of RPRD1A using immunohistochemistry in a microarray of GC patients with GC from our institution. This evidence concerns the gene RPRD1A and gastric cancer.